We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on...
Read ArticlePerversely, Polynovo stands to benefit from a US reimbursement cut for outpatients ASX biotechs had...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleNeuren’s US partner Acadia reports a 14% sales boost Look out for a slew of advanced clinical trial...
Read ArticleThe S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining mome...
Read ArticleEye drug developer Opthea’s cash balance has more than halved as the company wraps up its failed tr...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleNeurizon Therapeutics (ASX:NUZ) has this week arrived at its next “watershed moment” as it looks to...
Read ArticleThe ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6...
Read ArticleMarmota Limited (ASX:MEU) will be starting its first-ever drilling at Greenewood within the next wee...
Read ArticleIn this HotCopper Capital Compass interview, Race Oncology (ASX:RAC) chairman Dr Pete Smith discusse...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleActinogen Medical (ASX:ACW) has this week enrolled its 100th participant for its “pivotal” XanaMIA p...
Read ArticleHighlights BVF Partners exits Syntara citing fund size constraints, not program performance...
Read ArticleThe S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD dow...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Mo...
Read ArticleNova Eye and Syntara led today’s biotech relief rally, after the sector sunk on Wednesday on the ba...
Read ArticleDespite a late upturn, the ASX 200 closed 0.38% in the red on Thursday Blame factor 1: Trump and hi...
Read ArticleA cabal of ASX drug developers has defied the US gloom The healthcare jury’s out on new FDA head Dr...
Read ArticleThere are several ASX biotech companies developing drugs to treat complex neurological conditions G...
Read ArticleProfit-making ASX biotechs have been caught up in the market rout During Brain Health Week, let’s...
Read ArticleThe search for an effective treatment for neurological conditions like Alzheimer’s disease remains o...
Read ArticleThe S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Mo...
Read ArticleASX drops as Trump tariffs fuel market jitters Canada and China hit back with tariffs of their own...
Read ArticleHealthcare analysts say Neuren shares should be worth more than double what they are Biotech sector...
Read ArticleFinding a successful treatment for neurological conditions such as Alzheimer’s Disease is a pressing...
Read ArticleActinogen Medical Ltd (ASX:ACW) said its net loss after tax for the six months to December 2024 decr...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThe S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024 Mesobl...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThe ASX200 closed down 0.03% at 8,423 points. Gold rose after China’s central bank added bullion...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Hea...
Read ArticleFor years, people dreamed that science would one day create a pill to cure all ills. Today, one...
Read ArticleAmid improving sector sentiment, Actinogen says its Alzheimer’s trial is off to a flier Telix share...
Read ArticleActinogen Medical Ltd (ASX:ACW) has received a $9 million R&D (research and development) tax inc...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleEmvision expects to release trial results for its Emu stroke-detection device in November Syntara’s...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleCancer drug developer Chimeric Therapeutics eyes minimum $5 million raising ‘The next Telix’, Clari...
Read ArticleIf you have retirement on the horizon, then now could be the time to start thinking about building a...
Read ArticleS&P/ASX 200 Index (ASX: XJO) tech stock NextDC Ltd (ASX: NXT) has had a great run over the past...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleRenewed optimism lifted the S&P/ASX 200 by 3% in September, closing at a record 8,239.20 points...
Read ArticleInvestors that are on the lookout for ASX tech shares to buy might want to check out the two in this...
Read ArticleWanting exposure to the retail sector? Then it could pay to listen to what analysts at Bell Potter a...
Read ArticleActinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression...
Read ArticleAnalysts at Morgans have been busy looking back at last month's earnings season and have identified...
Read ArticleThere are some wonderful S&P/ASX All Ordinaries Index (ASX: XAO) shares that could be worth owni...
Read ArticleAussie electronics store JB H-Fi Ltd (ASX: JBH) has been one of the best-performing ASX retail stock...
Read ArticleRecent updates highlight significant strides in the biopharmaceutical sector. Paradigm Biopharmaceut...
Read ArticleHealth Check (briefly called Alive and Kicking before we grew tired of the Simple Minds tune running...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a subdued session on Wednesday. At the time of writ...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleASX hits all-time high before retreating slightly Gold miners surge as prices near record high Ho...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleThe S&P/ASX 200 Information Technology sector rose ~8% in August, despite a volatile month for...
Read ArticleS&P/ASX 200 recovers from heavy volatility early in the month to finish up 0.47% in August S&am...
Read ArticleThis week’s Bulls N’ Bears Runner of the Week is … MC Mining. The South African-focused coal produce...
Read ArticleAussie shares rose on Fed rate cut hopes Kelsian plunged, while Kalina, Actinogen and Kogan surged...
Read ArticleAustralian biotechnology company Actinogen Medical (ASX: ACW) has received further positive analysis...
Read ArticleActinogen doubled on positive Phase 2a results for Xanamem Xanamem’s durability leads to a Phase 2b...
Read ArticleActinogen Medical (ASX:ACW) has announced positive results from its XanaCIDD phase 2a depression t...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleActinogen (ASX:ACW) has reported success in using its novel antidepressant Xanamem to mitigate the s...
Read ArticleASX health stocks rise 0.8% past five days as broader market lifts 3.7% Morgans says ProMedicus ‘p...
Read ArticleWhile the S&P/ASX 200 Index (ASX: XJO) is enjoying a positive day, with the benchmark index up 0...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a decent gain. At t...
Read ArticleActinogen Medical (ASX:ACW) recently announced results from its XanaCIDD Phase 2a trials, which demo...
Read ArticleASX rises circa 0.5pc Consumer stocks in focus this week SGQ and PHX lead small caps Aussie stoc...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another solid gain....
Read ArticleTryptamine’s psilocybin trial indicates potential for treating fibromyalgia Actinogen says Xanamem...
Read ArticleIt has been a disastrous start to the week for Actinogen Medical Ltd (ASX: ACW) shares. In morning t...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at around 11-ish, which is meant to highlight the be...
Read ArticleThe ASX dropped, dragged down by Real Estate and Mining stocks Qantas cuts former CEO’s compensatio...
Read ArticleAn imminent trial result may validate whether Actinogen’s Xanamem is ‘the next Ozempic’. Originally...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleASX health stocks rise 2% in past five days as broader markets lift 0.6% Morgans upgrades disinfect...
Read ArticleA2 Milk Company Ltd (ASX: A2M) shares ended up having a stellar finish to the year in FY24. In t...
Read ArticleA2 Milk Co Ltd (ASX: A2M) shares are in the green today. Shares in the S&P/ASX 200 Index (ASX...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleIMM files a pre-IND application with US FDA for IMM-529 targeting common pathogen clostridioides di...
Read ArticleS&P/ASX 200 rose 1% in June with large caps leading gains with mid, small and emerging companie...
Read ArticleThis week’s Bulls N’ Bears Runner of the Week is … InteliCare Holdings. Its share price jumped 144 p...
Read ArticleASX 200 hit by afternoon profit taking, closing at +0.1pc for the day. 9 of 11 ASX sectors were h...
Read ArticleASX200 falls fast for a second session after inflation steals the air in the room 7 of 11 ASX sect...
Read ArticleTax-loss selling could be pile-driving fundamentally good companies into the ground. At least, that'...
Read ArticleASX falls 0.7pc on sticky CPI read Consumer Discretionary stocks dragged down by CKF and HVN Top s...
Read ArticleASX falls 0.7pc on sticky CPI read Consumer Discretionary stocks dragged down by CKF and HVN Top s...
Read ArticleA biomarker trial of Actinogen Medical’s (ASX: ACW) lead candidate Xanamem has been published in the...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a tough time on Wednesday after a stronger than expec...
Read ArticleAfter closing up 1.4% on Tuesday, the S&P/ASX 200 Index (ASX: XJO) looks ready to give back mos...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleActinogen Medical (ASX:ACW) has announced the successful completion of its non-renounceable...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleThe ASX200 closed .6 of a per cent up with every sector finishing in the green and consumer discreti...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThe ASX has plunged alongside Wall Street on jitters of higher US rates for longer All 11 sectors c...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticlePlus, Actinogen receives approval of its application for a UK Innovation Passport as part of the...
Read ArticleActinogen Medical (ASX: ACW) has treated the first subject in its clinical trial of patients with bi...
Read ArticleAtomo announces more purchase orders for HIV Self-Tests Actinogen says first patient was treated in...
Read ArticleNyrada jumped 400pc in a single day last month The company reported good results from its Brain Inj...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleResearch reports on ASX-listed companies, to download in full. **** -Actinogen Medical ((ACW)) by Ed...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleOne in eight people in the world have some form of mental disorder TrivarX’s AI technology diagnose...
Read ArticleLocal markets ride commodities lift to offset weak performance from Wall Street on Friday ASX 200...
Read ArticleThe ASX benchmark has closed slightly lower on Friday Losses across the Energy Sector weighed Smal...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleThe ASX has ended -0.4% lower, just 2.5 points from 2023 parity Utilities only sector in green Smal...
Read ArticleResearch reports on ASX-listed companies, to download in full. **** -Actinogen Medical ((ACW)) by Re...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleXanamem® is an oral, brain-penetrant tissue cortisol synthesis inhibitor that has shown promising...
Read ArticleBenchmark ASX index finishes +1% higher ASX Sectors led by Utilities (+4.2%) and all ended higher...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleHighlights Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years...
Read ArticleOn Tuesday, the Australian stock market experienced a decline primarily due to a sell-off in technol...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleUS FDA requested Botanix to change its instructions paper Antisense says ATL1102 could be effective...
Read ArticleThe ASX opened lower by 0.4% on Tuesday, reflecting market adjustments in anticipation of prolonged...
Read ArticleLake Resources (ASX:LKE) has announced a successful completion of the lithium carbonate test progr...
Read Article26 Sep 2023 - A snapshot of the stocks on the move, featuring Lake Resources (ASX:LKE), Talon Energy...
Read ArticleResearch reports on ASX-listed companies, to download in full. **** –Actinogen Medical ((ACW)) by Ed...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleThe company said the funds raised will be used to progress its Phase 2 clinical trial progra...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleNeuren’s US FDA approval for trofinetide has seen its share price boosted ~130% in past year Eye...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleASX health stocks fall 2.4% in the past five days in line with broader markets Mesoblast crashes mo...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleThe ASX 200 has had its worst day in roughly a month with a 1.29 percentage dip The sectors were a...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe ASX was higher by around 2.5% in July The best sectors were Tech and Energy We look at the best...
Read ArticleActinogen Medical's (ASX:ACW) chief medical officer, Dr Dana Hilt, has presented an academic...
Read ArticleResearch reports on ASX-listed companies, to download in full. **** –Actinogen Medical ((ACW)) by Ed...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleXanamem® is an oral, brain-penetrant tissue cortisol synthesis inhibitor that has shown promising...
Read ArticleResearch reports on ASX-listed companies, to download in full. –Actinogen Medical ((ACW)) by Edison...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleShareCafeIron ore surge not enough to lift the ASX: Aus shares close 0.16% lower by Peter Milios I...
Read ArticleShareCafeASX down 0.15% at noon despite spike in US markets by Peter Milios The global race for li...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleActinogen Medical (ACW) receives approval from the USA FDA to proceed with its six-month, phase 2b,...
Read ArticleActinogen Medical is a biotech with a potentially "gazillion" dollar opportunity in its Alzheimer's...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleShareCafeWebinar Recap – ACW, EEG & KNB Catch up on the full webinar presentations from Actinog...
Read ArticleShareCafeActinogen Medical (ASX:ACW) – Webinar Presentation Dr. Steven Gourlay – Managing Director...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes for ASX-lis...
Read ArticleASX 200 ends 1.4% lower Small caps slide 0.4% Strike strikes and I don’t know why The ASX 200 a...
Read ArticleASX 200 abandoned play after decent start Small cap index gives back 1.3% Dundas shares jump on ul...
Read ArticleClinical Dementia Rating Scale – Sum of Boxes effect of 0.6 to 0.8 points observed in patients with...
Read ArticleActinogen Medical (ACW) sees new “positive” data from its phase 2A Alzheimer Disease (AD) biomarker...
Read ArticleASX slides early and long on Monday Small cap index crashes -2.3% Besra Gold (ASX:BEZ) just tripled...
Read ArticleThe share market started the week with a sharp loss as investors booked profits from last week’s ral...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and droppe...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is down 1.69% today, but one ASX biotech share is bucking the...
Read ArticleShareCafeRough start to the week, all sectors in the red: ASX down 1.4 per cent at noon by Lauren Ha...
Read ArticleShareCafeStocks of the Hour: HLX, ACW, GAL Helix Resources (ASX:HLX) provid...
Read Article10 Oct 2022 - A snapshot of the stocks on the move featuring Helix Resources (ASX:HLX), Actinogen Me...
Read ArticleAustralian shares fell for a second day as US equity futures retreated ahead of inflation data and t...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleBenchmark finishes up after fierce struggle for buoyancy Absolutely no one shocked to learn Star’s...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleActing out your dreams could be a sign of a neurological disease, a study finds ASX-listed Pharmaxi...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleActinogen Medical (ASX:ACW) has provided further information on the timing and design of its...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes for ASX-lis...
Read ArticleActinogen Medical (ACW) finalises the designs for its planned phase two trials in Alzheimer’s Disea...
Read ArticleASX Health stocks endure another topsy-turvy week ending in red Monash IVF makes two key purchases...
Read ArticleHighlights The ASX Small Ordinaries index surged 1.59% to 2,987 by 12:30 PM AEST today. OZM, SB...
Read ArticleActinogen (ACW) announced it will prioritises its phase two trials in Alzheimer’s disease and depre...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleActinogen Medical (ACW) confirms positive topline results from its XanaMIA Part A trial, meeting pr...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleThe ASX will head into the Anzac day long weekend on a slightly sour note following a Friday selloff...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleHighlights Biotechnology companies research living organisms to develop drugs and other products...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleAt the time of writing, the ASX 200 Health Index (XHJ) is down 2%, while the benchmark ASX 200 is al...
Read ArticleActinogen Medical (ACW) completes final participant visits for the XanaMIA Part A trial which the c...
Read ArticleActinogen Medical (ACW) appoints a trial manager for its XanaFX phase-two trial in adolescent boys...
Read ArticleMotion analysis device maker dorsaVi (ASX:DVL) has been awarded the internationally recognised ISO 2...
Read ArticleReturns in the ASX healthcare basket were fairly robust throughout 2021. Sector earnings saw a retu...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleThe Actinogen Medical Ltd (ASX: ACW) share price soared today after the company announced a partner...
Read ArticleActinogen Medical (ACW) is collaborating with Oxford University researchers to investigate Xanamem...
Read ArticleThe ASX 200 Health Index (XHJ) is down by 0.80% at the time of writing, compared to the broader inde...
Read ArticleASX recovered some lost ground in arvo trade but still finished 0.54% down, as markets continue to b...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleActinogen Medical (ACW) places its shares in a trading halt to finalise the details of an upcoming...
Read ArticleThe Australian bourse recouped most of yesterday’s losses despite tech stocks dropping again, this t...
Read ArticleBell Potter has been tapped to help Actinogen Medical to support the expansion of its clinical trial...
Read ArticleThe ASX closed down again today in spite of resources and tech gaining over 1%. The ASX 200 fell 0.2...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has dropped back into the red. At the time...
Read ArticleShares in Australian biotech Actinogen Medical Ltd (ASX: ACW) are crawling lower today, currently t...
Read ArticleHighlights Despite going through a rough patch, few ASX shares have gained over 400% from the p...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleThe ASX 200 rose 0.41% to close at 7,535 while the ASX Emerging Companies Index gained another 1.36%...
Read ArticleLocal markets continued their strong form on Wednesday as the ASX rose for the third straight sessio...
Read ArticleIt was another positive close for the Australian bourse today with energy the standout sector. The A...
Read ArticleHighlights Actinogen Medical has completed the global grant process for Xanamem with the officia...
Read ArticleIDT Australia (ASX:IDT) jumped more than 20% after announcing that it has formalised activities with...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleShareCafeActinogen Medical Limited (ASX: ACW) – Webinar Presentation Steven Gourlay – CEO & MD –...
Read ArticleShareCafeA pipeline of disease applications within one pill Steven Gourlay – CEO & MD – Actinoge...
Read ArticleShareCafeHidden Gems Webinar Recap – NAOS Asset Management, MMM, NTI & ACW Catch up on the ful...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleThe Actinogen Medical Ltd (ASX: ACW) share price is soaring today after the company announced news...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleIn FY21 the ASX 200 returned over 20 per cent but the 100 best performing ASX stocks all gained over...
Read ArticleOver the past month, a number of US FDA approvals have moved the share prices of global pharma stock...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleIn early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is out of form and tumbling lower. A...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleThe Actinogen Medical Ltd (ASX: ACW) share price has been a strong performer on Wednesday morning....
Read ArticleShares in Actinogen Medical Ltd (ASX: ACW) soared today after the company released news on the upco...
Read ArticleSummary The ASX 200 closed sharply lower by 133.60 points or 1.81% at 7,235.30. The market witn...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleWhether it’s ultimately justified or not, the US Food and Drug Administration’s approval of an appar...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleRecent advances in our still-shallow understanding of the human brain have led to a renewed interest...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleComing up to the halfway mark of 2021, it is worth reflecting on what ASX shares have been the bigg...
Read ArticleThe Actinogen Medical Ltd (ASX: ACW) share price has been an investor’s dream of late, rising 414%...
Read ArticlePeter Switzer sits down with the CEO and Managing Director of Actinogen Medical (ACW), Dr Steven Gou...
Read ArticleEach week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength In...
Read ArticleShareCafeAlzheimer’s Decision Sends Positive Message to Aussie Biotechs The US Food and Drug Adminis...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleCogstate (ASX:CGS) has become the latest ASX health stock to gain from an FDA green light even thoug...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleLast month, the ASX finally reached its pre-pandemic high, went in circles for a couple of weeks the...
Read ArticleInvestors will be watching for updates on Traka Resources (ASX:TKL) this week, after the gold explor...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleGoogle April 2021 and the first things you’ll find isn’t ASX winners but questions about COVID-19. J...
Read ArticleSummary Pharmaxis Ltd and Charlie Teo Foundation have identified a new drug that shows promise i...
Read ArticleThe capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the fir...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleActinogen Medical Ltd (ASX: ACW) shares are tumbling today after the company released its quarterly...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleActinogen Medical Ltd (ASX: ACW) shares are rocketing higher today and have now gained 165% since t...
Read ArticleMarch got off to a rough start, with ASX small caps suffering their worst week since October and the...
Read ArticleStockhead’s Hot Money Monday analysis is based on the Relative Strength Index (RSI) — a technical ga...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read Article2021 is set to be another big year for ASX capital raisings with solid volumes so far in 2021. In th...
Read ArticleActinogen Medical CEO Dr Bill Ketelbey speaks at the Switzer Small and Micro Cap Virtual Investor Da...
Read ArticleThe Actinogen Medical Ltd (ASX: ACW) share price jumped 4.5% on open this morning, after the compan...
Read ArticleActinogen (ASX:ACW) has reveals plans for two clinical trials it will conduct next year - against MC...
Read ArticleASX-listed Actinogen Medical is in front of potential investors seeking a $10 million equity injecti...
Read ArticleActinogen Medical (ASX:ACW’) has announced the appointment of Mr Jeff Carter as its new chie...
Read ArticleA quick wrap of the key winners and losers on Tuesday, June 2. Data is taken after the market closes...
Read ArticleFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH...
Read ArticleThe COVID-19 pandemic has led to 527 clinical trials being shut down in Australia and New Zealand th...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleWith the world focused on the outcome of clinical trials for a COVID-19 vaccine, new research may ad...
Read ArticleDementia already affects hundreds of thousands of people in Australia, and it’s only going to get wo...
Read ArticleYou may have heard the saying “it’s not brain surgery” in the context of trying to prove something e...
Read ArticleWho said you have to be patient to net a hefty return on an investment? There are 10 ASX small caps...
Read ArticleThere are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so...
Read ArticleThe 10th Annual Australian Microcap Investment Conference will be held on Tuesday 22 October 2019 ov...
Read ArticleInvestors, brokers, high-ranking delegates, big pharma and Aussie small caps will all be sharing a r...
Read ArticleThe Board of advanced Australian lithium developer Core Lithium (ASX: CXO) has announced the appoint...
Read ArticleBy Tim Boreham, Editor, The New Criterion When a stock is trading at a fraction of a cent, it’s usu...
Read ArticleIn 2019, 10 stocks have gained more than 200 per cent in a single day. Stockhead recaps these stocks...
Read ArticleEach Monday, Stockhead recaps which stocks are heavily demanded by investors — or running hot. Stock...
Read ArticleIt wasn’t quite a case of ‘Lazarus with a triple bypass’, but a recovery of miraculous proportions d...
Read ArticleShareCafePicking The One Cent Wonders That Could Become Dollar Dazzlers When a stock is trading a...
Read ArticleWhat's hot Immuron Limited (ASX:IMC) Immuron closed up 66% to finish at 17.5c on $3.69 million stock...
Read ArticleOn Stockhead today: are semiconductors about to pick up again, California’s first pot cafe opens, bi...
Read ArticleThe three best-performing health and biotech companies in the past fortnight have all seen their sha...
Read ArticleThe Australian benchmark index S&P/ASX200, last traded on 2 October 2019, at 6639.9 points, down...
Read ArticleOn Tuesday, Actinogen Medical (ASX:ACW) released extremely promising results from the XanaHES (Xanam...
Read ArticleOn 1 October 2005, I was only 20 metres away from a large bomb that went off in the heart of Kuta. T...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleOn Stockhead today: Tim Treadgold on why gold miner Pantoro is a stock to watch, milk stocks in heal...
Read ArticleThe Actinogen Medical Ltd (ASX: ACW) share price is up 466% today from 0.9 cents to 5.1 cents after...
Read ArticleActinogen Medical (ASX: ACW) has announced “breakthrough” results from its XanaHES higher dose safet...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleOn Stockhead today: Aussie small caps trying to tackle the opioid crisis, which car manufacturers wi...
Read ArticleOn Stockhead today: our report on the 100 best performing stocks for the year, how four directors pu...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleEach Monday, Stockhead recaps which stocks are heavily demanded by investors – or running hot. Stock...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
